Adjunctive skin care in the management of rosacea: Cleansers, moisturizers, and photoprotectants

Cutis

Volumn 75, Issue 3 SUPPL., 2005, Pages 17-21

  Del Rosso, James Q ^{a,b,c,d,e,f,g,h,i}  

^a UNIVERSITY OF NEVADA   (United States)

^b Berlex Laboratories   (United States)

^c Managed Care and Professional Affairs   (United States)

^d Bradley Pharmaceuticals Inc   (United States)

^e Galderma Laboratories   (United States)

^f Healthpoint Ltd   (United States)

^g Medicis ^*  (France)

^h Stiefel Laboratories Inc   (United States)

ⁱ UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOMETHICONE; DIMETICONE; HUMECTANT; METRONIDAZOLE; SILICONE DERIVATIVE; SULFACETAMIDE; SULFUR; UNCLASSIFIED DRUG;

ACNE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; EPIDERMIS; HUMAN; PATIENT EDUCATION; ROSACEA; SEBORRHEIC DERMATITIS; SKIN CARE; SKIN IRRITATION; SKIN SENSITIVITY; STRATUM CORNEUM;

ALGORITHMS; ANTI-INFECTIVE AGENTS, LOCAL; DETERGENTS; EMOLLIENTS; FACE; HUMANS; PHOTOSENSITIVITY DISORDERS; ROSACEA; SKIN; SKIN CARE; SULFACETAMIDE; SUNSCREENING AGENTS; WATER LOSS, INSENSIBLE;

EID: 17144403451     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Drake L. New survey pinpoints leading factors that trigger symptoms. Rosacea Rev. Winter 2003.
2. Wilkin JK. Oral thermal-induced flushing in erythrotelangiectatic rosacea. J Invest Dermatol. 1981;76:15-18.
3. Tisma VS, Basta-Juzbasic A, Dobric I, et al. Etiopathogenesis, classification, and current trends in treatment of rosacea. Acta Dermatovenerol Croat. 2003;11:236-246.
4. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20:199-206.
5. Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
6. Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol. 1992;26:590-593.
7. Brinnel H, Friedel J, Caputa M, et al. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989;281:66-72.
8. Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136-1141.
9. Draelos ZD. Clinical situations conducive to proactive barrier enhancement. Cutis. 2002;70(suppl 6):17-20, 31-23.
10. Oztas MO, Balk M, Ogus E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol. 2003;28:188-192.
11. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999;79:460-461.
12. Draelos ZD. Cosmetics in acne and rosacea. Semin Cutan Med Surg. 2001;20:209-214.
13. Hawkins SS, Subramanyan K, Liu D, et al. Cleansing, moisturizing, and sun-protection regimens for normal skin, self-perceived sensitive skin, and dermatologist-assessed sensitive skin. Dermatol Ther. 2004;17(suppl 1):63-68.
14. Nichols K, Desai N, Lebwohl MG. Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis. 1998;61:344-346.
15. Torok HM. Rosacea skin care. Cutis. 2000;66(suppl 4):14-16.
16. Scheman AJ. Cosmetic intolerance: choosing products for sensitive skin. Cosmet Dermatol. July 1999;12:28-30.
17. Nedorost ST. Facial erythema as a result of benzophenone allergy. J Am Acad Dermatol. 2003;49(suppl 5):259-261.
18. Bikowski J. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis. 2001;68(suppl 5):12-19.
19. Bikowski J. The use of therapeutic moisturizers in various dermatologic disorders. Cutis. 2001;68(suppl 5):3-11.
20. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5:5-13.
21. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17:43-48.
22. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, et al. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004;17:16-25.
23. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17:6-15.
24. Meguro S, Arai Y, Masukawa Y, et al. Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res. 2000;292:463-468.
25. Johnson AW. Overview: fundamental skin care - protecting the barrier. Dermatol Ther. 2004;17:1-5.
26. Baranda L, Gonzalez-Amaro R, Torres-Alvarez B, et al. Correlation between pH and irritant effect of cleansers marketed for dry skin. Int J Dermatol. 2002;41:494-499.
27. Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther. 2004;17(suppl 1):26-34.
28. Swinyer L. Evaluation of a novel sodium sulfacetamide 10% and sulfur 5% prescription cleanser for the treatment of rosacea. Poster presented at: 59th Annual Meeting of the American Academy of Dermatology; March 2-7, 2001; Washington, DC. P147.
29. Beutner KR, Lemke S, Czernielewski J. Patient acceptability of a new fragrance-free sulfacetamide/sulfur cleanser. Poster presented at: 62nd Annual Meeting of the American Academy of Dermatology; February 6-11, 2004; Washington, DC. P205.
30. Amblard P, Leccia MT. Skin diseases with photosensitivity. Rev Prat. 1992;42:1365-1368.
31. Nole G, Johnson AW. An analysis of cumulative lifetime solar ultraviolet radiation exposure and the benefits of daily sun protection. Dermatol Ther. 2004;17(suppl 1):57-62.